Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TreximetTM in the Prevention and Modification of Disease Progression in Migraine

NCT01300546 is registered in ClinicalTrials.gov with Cady, Roger, M.D. as lead sponsor.

NCT NCT01300546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01300546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TreximetTM in the Prevention and Modification of Disease Progression in Migraine
Lead sponsor
Cady, Roger, M.D.
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2010
Completion date
April 30, 2012
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine